Stifel Financial’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
AIM
FCM
VPM
AVM
VCM
NAMA
Stifel Financial's BEAM Position: Q1 2026 in Review
Stifel Financial reduced its Beam Therapeutics (BEAM) stake by 7.4% in Q1 2026, selling an estimated $27.5K and leaving 12,415 shares worth $296K. The position accounts for ﹤0.01% of the portfolio, ranked #3190.
Stifel Financial first reported a position in BEAM in Q3 2021 and has held it in 15 quarters since. The position peaked at $457K in Q3 2022. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.
- Stifel Financial held 12,415 shares of Beam Therapeutics worth $296K as of Q1 2026.
- Stifel Financial sold 990 Beam Therapeutics shares in Q1 2026, an estimated $27.5K.
- Beam Therapeutics made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #3190 holding.
- Stifel Financial first reported a position in Beam Therapeutics in Q3 2021 and has held it in 15 quarters since.
- Stifel Financial's Beam Therapeutics position peaked at $457K in Q3 2022.
- 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.
Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.